Northern Trust Corp Processa Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.18 - $0.84 $2,292 - $10,699
12,738 Added 82.71%
28,139 $9,000
Q3 2021

Nov 15, 2021
BUY
$5.28 - $8.61 $13,495 - $22,007
2,556 Added 19.9%
15,401 $132,000
Q1 2021

May 12, 2021
BUY
$5.96 - $13.15 $76,556 - $168,911
12,845 New
12,845 $140,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $15.5M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email